BIOLUMINUX CLINICAL RESEARCH NEW JERSEY
NPI 1275354334
Clinic/Center - Research in Trenton, NJ
About Bioluminux Clinical Research New Jersey NPPES
Official registry information on file with the National Plan and Provider Enumeration System.
BIOLUMINUX CLINICAL RESEARCH NEW JERSEY (NPI 1275354334) is a healthcare organization registered as a research in Trenton, New Jersey and active in the NPI registry since October 2024. The organization holds a CLIA Waiver certificate valid through October 6, 2026 and lists Matthew Oyeyemi Adasofunjo, Managing Director, as its authorized official.
NPPES Registry Identity
Specialties & Licenses
CLIA Laboratory Certificates CMS CLIA
Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.
Certificate of Waiver 31D2312185
Bioluminux Clinical Research New Jersey LLC · Hamilton, NJFrequently Asked Questions NPPES & CMS
Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.
What is Bioluminux Clinical Research New Jersey's NPI number?
The NPI number for Bioluminux Clinical Research New Jersey is 1275354334. It was assigned to this organization in the NPPES registry on October 22, 2024.
Where is Bioluminux Clinical Research New Jersey located?
Bioluminux Clinical Research New Jersey is located at 2131 Route 33 Ste B, Trenton, NJ 08690. The listed phone number is (708) 435-1404.
What is Bioluminux Clinical Research New Jersey's specialty?
The primary specialty registered for this NPI is Clinic/Center, specializing in Research, with taxonomy code 261QR1100X.
Does Bioluminux Clinical Research New Jersey hold a CLIA laboratory certificate?
Yes. A Certificate of Waiver (number 31D2312185) is associated with this NPI, valid through October 6, 2026. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.
When was this NPI record last updated?
The NPPES record for Bioluminux Clinical Research New Jersey was last updated on October 22, 2024. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 21 months ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.